Hea‐Nam Hong
- Co-authors
- Shin HwangSung‐Gyu LeeGi‐Young KoKyu‐Bo SungBum Soo KimSung‐Koo LeeMyung‐Hwan KimDong‐Hou Kim
- Topics
- Neuroscience and Neuropharmacology Research (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (2 papers)Alzheimer's disease research and treatments (2 papers)
- Partner nations
- South Korea
In The Last Decade
Hea‐Nam Hong
17 papers receiving 412 citations
Peers
Comparison fields: 5 of 75
- Hepatology 139
- Molecular Biology 124
- Surgery 119
- Epidemiology 78
- Oncology 58
Countries citing papers authored by Hea‐Nam Hong
This map shows the geographic impact of Hea‐Nam Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hea‐Nam Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hea‐Nam Hong more than expected).
Fields of papers citing papers by Hea‐Nam Hong
This network shows the impact of papers produced by Hea‐Nam Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hea‐Nam Hong. The network helps show where Hea‐Nam Hong may publish in the future.
Co-authorship network of co-authors of Hea‐Nam Hong
This figure shows the co-authorship network connecting the top 25 collaborators of Hea‐Nam Hong. A scholar is included among the top collaborators of Hea‐Nam Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hea‐Nam Hong. Hea‐Nam Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression. | 30 |
| 3 | Synergistic effect of sorafenib and vitamin K on suppression of hepatocellular carcinoma cell migration and metastasis. | 23 |
| 4 | 6 | |
| 5 | 31 | |
| 6 | 119 | |
| 7 | 26 | |
| 8 | 51 | |
| 9 | 8 | |
| 10 | 12 | |
| 11 | 21 | |
| 12 | 16 | |
| 13 | 12 | |
| 14 | 18 | |
| 15 | 22 | |
| 16 | 11 | |
| 17 | 2 |
About Hea‐Nam Hong
Hea‐Nam Hong is a scholar working on Applied Microbiology and Biotechnology, Hepatology and Developmental Neuroscience, having authored 17 papers that have together received 417 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Hepatology (139 citations), Nutrition and Dietetics (49 citations) and Surgery (119 citations). Hea‐Nam Hong has collaborated with scholars based in South Korea. Frequent co-authors include Shin Hwang, Sung‐Gyu Lee, Gi‐Young Ko, Kyu‐Bo Sung, Bum Soo Kim, Sung‐Koo Lee, Myung‐Hwan Kim, Dong‐Hou Kim, Jong‐Hwan Lee and Jae‐Wan Huh. Their work appears in journals such as Annals of Surgery, Brain Research and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.